Bio Pharma Dive
JANUARY 19, 2022
Hal Barron, a key figure in GSK's efforts to revitalize its drug research, will step down as its top scientist at a time when the company is feeling heat from investors to deliver faster growth.
pharmaphorum
JANUARY 19, 2022
Just months after the venture was unveiled, controversial biotechnology company Altos Labs has officially launched with $3 billion in funding secured from investors. Dubbed an ‘anti-ageing’ company, Altos has gained mainstream attention for its focus on ‘rejuvenation’ and biological reprogramming technology. While the specific research goals have been kept a closely guarded secret, some scientists propose that rejuvenating cells in a lab could be a path to prolonging huma
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 19, 2022
Study results show EQRx's drug, which it means to position as a lower-cost alternative to widely used cancer immunotherapies, extended the lives of lung cancer patients. But it's unclear whether that will be enough to sway the FDA.
BioPharma Reporter
JANUARY 19, 2022
Automated cell therapy manufacturing processes could reduce manual intervention and human errors, enabling more robust processes, improved product quality, and lower costs.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
JANUARY 19, 2022
The acquisition will give the Belgian pharma access to an epilepsy drug that won U.S. approval in June 2020 but that Zogenix has struggled to sell.
Fossil Remedies
JANUARY 19, 2022
We know that the PCD Pharma Franchise business is lucrative and profitable. But do we know which PCD products should we pick so that the maximum profitability is ensured? Perhaps no. This blog is an attempt to clarify the concepts about choosing the best products. First, choose the right company. Experts say that one should choose an ISO-certified company that works as per the standards and guidelines laid by WHO and GMP.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
XTalks
JANUARY 19, 2022
The way in which clinical trials are conducted is entering a new dimension as clinical trial operations are becoming more adaptable. The COVID-19 pandemic has caused a significant increase in the number of decentralized clinical trials (DCTs), which are performed away from primary clinical research study sites, as well as hybrid clinical trials (HCTs), which use a combination of centralized, site-based models and decentralized methods.
Pharma Marketing Network
JANUARY 19, 2022
Talk to me. Pharma brands that want deep engagements need to look at and listen to social audio. It’s not surprising. In fact, it’s the most direct route to your goal. You want to talk to doctors? To start the conversation, we put pictures in front of them, bombarded them with videos, retarget them, and then send them emails. We want to talk, and they want to listen.
Scienmag
JANUARY 19, 2022
A study published in Indoor Air simulated the transmission of SARS-CoV-2, the virus that causes COVID-19, on a flight from London to Hanoi and on another flight from Singapore to Hangzhou. Credit: Dr. Lai A study published in Indoor Air simulated the transmission of SARS-CoV-2, the virus that causes COVID-19, on a flight from London […].
Drug Channels
JANUARY 19, 2022
For 2022, the three largest pharmacy benefit managers (PBMs)—Caremark (CVS Health), Express Scripts (Cigna), and OptumRx (United Health Group)— increased the number of drugs they excluded from their standard formularies. Each exclusion list contains 400 to 500 products. Growth in the number of excluded drugs slowed, due partly to the fact that so many drugs have already been dropped from PBMs’ formularies.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
JANUARY 19, 2022
The digital revolution generated by the pandemic fractured lines of connection and severed the life-blood of being able to meet with clinicians for sales teams and MSLs. It created a fundamental shift in operating practice that has skewed product launches, sales and scientific communication but experts are advocating that companies embrace the change and use it to energise performance.
Scienmag
JANUARY 19, 2022
The English Channel prevents many rockpool species “making the jump” from Europe to the UK, new research shows. Credit: Christophe Patterson The English Channel prevents many rockpool species “making the jump” from Europe to the UK, new research shows. With sea temperatures expected to rise due to climate change, many rockpool species in south-west England […].
Pharma Times
JANUARY 19, 2022
Imfinzi has shown improvements in the overall survival of patients with biliary tract cancer
Scienmag
JANUARY 19, 2022
Despite restrictions, recreational cannabis companies use marketing that appeals to adolescents: Study Credit: Rutgers Center of Alcohol & Substance Use Studies Despite restrictions, recreational cannabis companies use marketing that appeals to adolescents: Study By Kimberly Flynn PISCATAWAY, NJ — Many recreational cannabis companies market their products in a way that appeals to children and teens, […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
JANUARY 19, 2022
NICE also aims to make strides in digital, genomic and antimicrobial technologies
Scienmag
JANUARY 19, 2022
Assistant professor Cristina Thomas of Northern Arizona University has been named an Emerging Scholar by the leading education magazine Diverse: Issues in Higher Education in its Jan. 20, 2022 issue. The publication annually recognizes an interdisciplinary group of early-career minority scholars who represent the best of U.S. academia. Credit: Northern Arizona University Assistant professor Cristina […].
pharmaphorum
JANUARY 19, 2022
Research into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the process. The collaboration aims to “close the gap between single-cell RNA sequencing wet-lab services and single-cell data analysis solutions,” which will allow scientists to study the finest details that can be hard to access.
Scienmag
JANUARY 19, 2022
WASHINGTON — Researchers have developed an adaptive liquid lens based on a new electrically responsive fluid called dibutyl adipate (DBA) that changes focal length when a voltage is applied. The lens is lightweight, compact and simple to fabricate, which makes it ideal for mobile phone cameras, endoscopes, eyeglasses and machine vision applications.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
NY Times
JANUARY 19, 2022
The experience showed how hard it is for many people to get potentially lifesaving treatments.
Scienmag
JANUARY 19, 2022
Scientists look to space for origins of the solar system; chemical engineers like Poornima Padmanabhan are searching for the origins of life based on minute systems of molecules. Credit: A. Sue Weisler/RIT Scientists look to space for origins of the solar system; chemical engineers like Poornima Padmanabhan are searching for the origins of life based […].
pharmaphorum
JANUARY 19, 2022
Lung cancer drug sugemalimab has delivered positive results following a phase 3 trial. EQRx’s GEMSTONE-302 study evaluated the efficacy and safety of the investigational anti-PD-L1 antibody, sugemalimab, in combination with chemotherapy as a first-line treatment for patients with stage four non-small cell lung cancer (NSCLC), versus using chemotherapy alone.
Scienmag
JANUARY 19, 2022
Often portrayed as destructive monsters that hold light captive, black holes take on a less villainous role in the latest research from NASA’s Hubble Space Telescope. A black hole at the heart of the dwarf galaxy Henize 2-10 is creating stars rather than gobbling them up. The black hole is apparently contributing to the firestorm […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
NY Times
JANUARY 19, 2022
In “The Hard Sell,” the journalist Evan Hughes tells the story of the rise and fall of Insys Therapeutics — and the larger pharmaceutical industry.
Scienmag
JANUARY 19, 2022
NEWS RELEASE Credit: Brandon Martin/Rice University NEWS RELEASE Jeff Falk 713-348-6775 jfalk@rice.edu Mike Williams 713-348-6728 mikewilliams@rice.edu When graphene speaks, scientists can now listen Brothers in Rice lab find audio from graphene production contains valuable data HOUSTON – (Jan. 19, 2022) – It may be true that seeing is believing, but sometimes hearing can be better. […].
pharmaphorum
JANUARY 19, 2022
Once widely acknowledged as so special that only scientists and clinical specialists need apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade. Yet how many other therapy areas have market leaders that don’t even have clinical approval in that indication?
Scienmag
JANUARY 19, 2022
One of the key components behind next-generation high resolution video displays will be optical nanoantennas. These devices use nanotechnology to mix and interfere with light beams to produce colour and even holograms. Credit: SUTD One of the key components behind next-generation high resolution video displays will be optical nanoantennas. These devices use nanotechnology to mix […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
FDA Law Blog
JANUARY 19, 2022
By Adrienne R. Lenz, Principal Medical Device Regulation Expert — Closed-loop control systems, which adjust device output based on information received from a sensor to keep a variable at a reference position, are common in many medical devices. There are numerous examples where device output is controlled to maintain a physical measurement, such as pressure, at a set point.
Scienmag
JANUARY 19, 2022
New research suggests manufacturers of newly developed antidepressant drugs have become more forthcoming about clinical trials that don’t pan out. A new review and meta-analysis, published today in the journal PLOS Medicine, indicates that drug companies conducting clinical trials on new antidepressants have increased disclosure of clinical trials with negative outcomes, that is, trials that […].
FDA Law Blog
JANUARY 19, 2022
By Adrienne R. Lenz, Principal Medical Device Regulation Expert — Closed-loop control systems, which adjust device output based on information received from a sensor to keep a variable at a reference position, are common in many medical devices. There are numerous examples where device output is controlled to maintain a physical measurement, such as pressure, at a set point.
Scienmag
JANUARY 19, 2022
Camels have a renowned ability to survive on little water. They are also adept at finding something to drink in the vast desert, using noses that are exquisite moisture detectors. In a new study in ACS Nano, researchers describe a humidity sensor inspired by the structure and properties of camels’ noses. In experiments, they found […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
363 
Let's personalize your content